Home
Database Statistics
Help System
About
Literature
Projects
Events
Login / Register
Mepolizumab to treat eosinophilic granulomatosis with polyangiitis.
2024
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Unidad de Enfermedades Sistémicas, Servicio de Medicina Interna, Hospital Clínico Universitario San Cecilio, Granada, España. Electronic address: jlcalleja@telefonica.net.
Associated MeSH Terms
Cite
UI
MeSH Term
Description
Entries
Related Publications
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Vasculitis: Mepolizumab for eosinophilic granulomatosis with polyangiitis.
September 2017, Nature reviews. Rheumatology,
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Mepolizumab in patients with eosinophilic granulomatosis with polyangiitis.
August 2019, The Journal of allergy and clinical immunology,
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Mepolizumab Treatment of Pediatric Eosinophilic Granulomatosis With Polyangiitis.
April 2018, JAMA dermatology,
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
May 2017, The New England journal of medicine,
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
May 2024, The New England journal of medicine,
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
March 2024, The New England journal of medicine,
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
February 2018, Drugs of today (Barcelona, Spain : 1998),
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis. Reply.
May 2024, The New England journal of medicine,
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Mepolizumab for the treatment of eosinophilic granulomatosis with polyangiitis.
July 2019, Expert opinion on biological therapy,
Jose Luis Callejas Rubio, and Manuela Moreno Higueras, and Norberto Ortego Centeno
Mepolizumab and Eosinophilic Pleural Effusion in Patient With Eosinophilic Granulomatosis With Polyangiitis.
July 2023, Archivos de bronconeumologia,
Export Citation
×
Select Citation Style to be generated
APA
Vancouver
Harvard
BibTeX
Endnote
Generated Citation:
Selection Actions
Export Citations
Download Data
Save To My Collection
Need Help?
Explore features, get started with a guided tour, or view relevant help articles.
Start Tour
Go to Related Help Article
Copied contents to your clipboard!
Publications over Time
×
Save Item To Your Collection
×
Collection Name
Your saved publications will be grouped by this name - think of it like a folder to group related publications and results.
Use default name